Sudan Journal of Medical Sciences
ISSN: 1858-5051
High-impact research on the latest developments in medicine and healthcare across MENA and Africa
Histopathologic Pattern of Thyroid Disease in 1351 Thyroidectomy Patients
Published date: Dec 31 2022
Journal Title: Sudan Journal of Medical Sciences
Issue title: Sudan JMS: Volume 17 (2022), Issue No. 4
Pages: 577–588
Authors:
Abstract:
BackgroundThyroid disease poses a major clinical problem. Knowledge of the pattern and distribution of thyroid disease is important to establish prevention and treatment protocols. This is hampered by lack of data.
MethodsThis is a retrospective descriptive study of histopathology reports on thyroid tissue surgically excised from patients over a 10-year-period (from 2009-2020) at a major teaching hospital. Demographic data on patients included the age, gender, geographical location and ethnic origin.
Results A total of 1351 histopathological reports on thyroid patients were studied. Twenty one patients (1.6%) had thyroglossal cysts and 1330 patients (98.4%) had goiters. The mean age was 40.6 years (SD±13.25), (range 11-85years). The majority (88%) were females Most of our patients come from Khartoum (76.3%), followed by White Nile (6.4%), and El Gazira states (4.5%). The commonest ethnic groups affected were the Nuba (11.6%) and Jaalin (8%). The majority of patients (85%) had benign thyroid diseases, and only (15%) had neoplastic disease. Simple multinodular goiter (SMNG) accounted for (78.6%) of benign thyroid disease. Follicular adenoma was the commonest benign neoplasm (98%), whereas papillary carcinoma was the commonest malignant tumour (44.9%), followed by follicular carcinoma and Hurthle cell tumours (43.9%). Medullary and anaplastic carcinomas each accounted for (4.1%) of patients.
Conclusions The study identified the histopathological pattern of thyroid disease. SMNG was the commonest benign disease. Follicular and Hurtle cell carcinoma combined were almost as frequent as papillary carcinoma. Prevention of SMNG by iodinization, early detection of thyroid neoplasms, and studies on goitrogens should be activated.
Keywords: Thyroid disease, histopathology, thyroglossal cyst, goiter thyroid cancer, thyroidectomy, Sudan, multinodular colloid goiter, thyroid adenoma
References:
[1] Ministry of Health. (1999). Directorate general primary health care, national nutrition department. IDD Baseline Survey Report. Khartoum: Sudan.
[2] Medani, A. M., Elnour, A. A., & Saeed, A. M. (2011). Endemic goitre in the Sudan despite long-standing programmes for the control of iodine deficiency disorders. Bulletin of the World Health Organization, 89(2), 121–126.
[3] Greig, W. R., Gray, H. W., McGirr, E. M., Kambal, A., & Rahman, I. A. (1970). Investigation of endemic goitre in Sudan. British Journal of Surgery; 57(1), 11–16.
[4] Eltom, M., Hofvander, I., Torelm, B., & Fellstrom, B. (1984). Endemic goiter in the Darfur region (Sudan); Epidemiology and aetiology. Journal of Internal Medicine, 215(5), 467–475.
[5] Greenwald, I. (1949). The history of goiter in Africa. Bulletin of the History of Medicine, 23(2), 155–174.
[6] Koyuncuer, A., Bayraktar, S. G., & Gürkan, E. (2016). Histopathologic examination of thyroidectomy specimens from 1149 nodular goiter patients. Actamedica Mediterranea, 32, 35–42.
[7] Segaye, B., & Ergete, W. (2003). Histopathologic pattern of thyroid disease. East African Medical Journal, 80(10), 525–528.
[8] Al-wageeh, S., Ahmed, F., Nikbakht, H. A., Al-shami, E., Askarpour, M. R., & Chowdhury, U. (2020). An investigation of the histopathological pattern of thyroid in patients undergoing thyroid operations: A cross-sectional study. Open Access Surgery, 13, 47–52.
[9] Chalya, P., Rambau, P., Mabula, J. B., Kanumba, E. S., Giiti, G., & Gilyoma, J. M. (2011). Patterns and outcome of surgical management of goitres at Bugando Medical Centre in northwestern Tanzania. Tanzania Journal of Health Research, 13(3), 1–9.
[10] ElMakki Ahmed, M. (2017, April 1–5). Thyroid carcinoma in The Sudan [abstract]. Proceedings of the American Association for Cancer Research Annual Meeting, Washington, DC.
[11] Osman, A. I. E., Almobarak, A. O., Mohammed, A. K., Mohamed, N. S., Muneer, M. S., Omer, A. B., Ibrahim, H. M. A., Siddig, E. E., Ali, E. T., Munir, A., Edris, A. M. M., Ahmed, E. S., Elnour, L. S., & Hassan, R. (2020). Cytomorphological patterns of thyroid lesions among 1646 Sudanese patients: What we can learn from fine needle aspiration cytology retrospective analysis? F1000Research, 9, 23.
[12] Cancer.Net. (2022). Thyroid cancer: Introduction. https://www.cancer.net/cancertypes/ thyroid-cancer/introduction
[13] Beahrs, O. H., & Myers, M. H. (1983). Manual for staging of cancer. The American Joint Committee on Cancer (2nd ed.). Philadelphia: J.B. Lippincott Company.
[14] Sobin, L. H., Gospodarowicz, M. K., & Wittekind, Ch., International Union against Cancer. (2009). TNM classification of malignant tumours. Hoboken, NJ: Wiley- Blackwell.
[15] Tuttle, M., Haugen, B., & Perrier, D. (2017). Updated American Joint Committee on Cancer/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): What changed and why? Thyroid, 27(6), 751–756.
[16] Kim, M., Kim, W. G., Oh, H. S., Park, S., Kwon, H., Song, D. E., Kim, T. Y., Shong, Y. K., Kim, W. B., Sung, T. Y., Jeon, M. J. (2017). Comparison of the seventh and eighth editions of the American Joint Committee on cancer/union for international cancer control tumor-node-metastasis staging system for differentiated thyroid cancer. Thyroid, 27(9), 1149–1155.
[17] Amin, M. B., Edge, S. B., Greene, F., Byrd, D., Brookland, R. K., Washington, M. K., Gershenwald, J. E., Compton, C. C., Hess, K. R., Sullivan, D. C., Jessup, J. M., Brierley, J., Gaspar, L. E., Schilsky, R. L., Balch, C. M., Winchester, D. P., Asare, E. A., Madera, M., Gress, D. M., & Meyer, L. R. (Eds.). (2017). AJCC cancer staging manual (8th ed.). New York, NY: Springer International Publishing.
[18] Fariduddin, M. M., & Syed, W. (2021). Hurthle cell thyroid carcinoma. Treasure Island (FL): StatPearls Publishing.
[19] Wei, S. (2022). Oncocytic (Hürthle cell) tumors. PathologyOutlines.com. https://www.pathologyoutlines.com/topic/thyroidhurthle.html
[20] Mc Henry, C., & Phytayakorn, R. (2011). Follicular adenoma and carcinoma of the thyroid gland. The Oncologist, 16, 585–593.
[21] Zimmermann, M. B., & Galetti, V. (2015). Iodine intake as a risk factor for thyroid cancer: A comprehensive review of animal and human studies. Thyroid Research, 8(8), 1–21.
[22] Galanti, R. M., Sparén, P. Ä. R., Karlsson, A., Grimelius, L., & Ekbom, A. (1995). Is residence in areas of endemic goiter a risk factor for thyroid cancer? International Journal of Cancer, 61(5), 615–621.
[23] Pettersson, B., Adami, H. O., Wilander, E., Coleman, M. P. (1991). Trends in thyroid cancer incidence in Sweden, 1958–1981, by histopathologic type. International Journal of Cancer, 48(1), 28–33.
[24] Burgess, J. R., Dwyer, T., McArdle, K., Tucker, P., & Shugg, D. (2000). The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978–1998) during a transition from iodine sufficiency to iodine deficiency. Journal of Clinical Endocrinology and Metabolism, 85(4), 1513–1517.
[25] Dom, G., Frank, S., Floor, S., Kehagias, P., Libert, F., Hoang, C., Andry, G., Spinette, A., Craciun, L., de Saint Aubin, N., Tresallet, C., Tissier, F., Savagner, F., Majjaj, S., Gutierrez-Roelens, I., Marbaix, E., Dumont, J. E., & Maenhaut, C. (2018). Thyroid follicular adenomas and carcinomas: molecular profiling provides evidence for a continuous evolution. Oncotarget, 9(12), 10343–10359.
[26] Doumi, E. A., Mohamed, I. M., Abaker, A. M., & Bakhiet, M. Y. (2009). Thyroidectomy at El Obeid hospital, Western Sudan. Khartoum Medical Journal, 2(1), 158–161.
[27] American Thyroid Association. (n.d.). Cancer of the thyroid. https://www.thyroid.org/cancer-of-the-thyroid/
